{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Rockford",
      "address_1": "1718 Northrock Ct",
      "reason_for_recall": "Failed Impurities/Degradation Specifications: out of specification result for Clonazepam Related Compound (RC) A (a known impurity) at 16 month timepoint.",
      "address_2": "",
      "product_quantity": "46,472 unit dose blister cards (10 cards of 10 tablets each)",
      "code_info": "Lot#: 3061784, Exp 11/16; 3067656, Exp 12/16; 3074902, Exp 08/17",
      "center_classification_date": "20161110",
      "distribution_pattern": "Nationwide",
      "state": "IL",
      "product_description": "Clonazepam Tablets, USP, 1.0 mg, packaged in a 100- count unit dose box of 10 x 10 blister cards, Rx only, Manufactured by Mylan Pharmaceuticals Inc, Morgantown, WV, 26505, NDC 51079-882-20",
      "report_date": "20161116",
      "classification": "Class III",
      "openfda": {},
      "recalling_firm": "Mylan Institutional, Inc. (d.b.a. UDL Laboratories)",
      "recall_number": "D-0136-2017",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "75295",
      "termination_date": "20180828",
      "more_code_info": "",
      "recall_initiation_date": "20160928",
      "postal_code": "61103-1201",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}